927 related articles for article (PubMed ID: 17671210)
1. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.
Ho GP; Margossian S; Taniguchi T; D'Andrea AD
Mol Cell Biol; 2006 Sep; 26(18):7005-15. PubMed ID: 16943440
[TBL] [Abstract][Full Text] [Related]
3. FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway.
Ishiai M; Kitao H; Smogorzewska A; Tomida J; Kinomura A; Uchida E; Saberi A; Kinoshita E; Kinoshita-Kikuta E; Koike T; Tashiro S; Elledge SJ; Takata M
Nat Struct Mol Biol; 2008 Nov; 15(11):1138-46. PubMed ID: 18931676
[TBL] [Abstract][Full Text] [Related]
4. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
Taniguchi T; Garcia-Higuera I; Xu B; Andreassen PR; Gregory RC; Kim ST; Lane WS; Kastan MB; D'Andrea AD
Cell; 2002 May; 109(4):459-72. PubMed ID: 12086603
[TBL] [Abstract][Full Text] [Related]
5. An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication.
Zhu W; Dutta A
Mol Cell Biol; 2006 Jun; 26(12):4601-11. PubMed ID: 16738325
[TBL] [Abstract][Full Text] [Related]
6. Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling.
Yamauchi M; Oka Y; Yamamoto M; Niimura K; Uchida M; Kodama S; Watanabe M; Sekine I; Yamashita S; Suzuki K
DNA Repair (Amst); 2008 Mar; 7(3):405-17. PubMed ID: 18248856
[TBL] [Abstract][Full Text] [Related]
7. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
8. Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage.
Castillo P; Bogliolo M; Surralles J
DNA Repair (Amst); 2011 May; 10(5):518-25. PubMed ID: 21466974
[TBL] [Abstract][Full Text] [Related]
9. ATR couples FANCD2 monoubiquitination to the DNA-damage response.
Andreassen PR; D'Andrea AD; Taniguchi T
Genes Dev; 2004 Aug; 18(16):1958-63. PubMed ID: 15314022
[TBL] [Abstract][Full Text] [Related]
10. Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.
Landais I; Hiddingh S; McCarroll M; Yang C; Sun A; Turker MS; Snyder JP; Hoatlin ME
Mol Cancer; 2009 Dec; 8():133. PubMed ID: 20043851
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
Dunn J; Potter M; Rees A; Rünger TM
Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
[TBL] [Abstract][Full Text] [Related]
12. BRCA1-independent ubiquitination of FANCD2.
Vandenberg CJ; Gergely F; Ong CY; Pace P; Mallery DL; Hiom K; Patel KJ
Mol Cell; 2003 Jul; 12(1):247-54. PubMed ID: 12887909
[TBL] [Abstract][Full Text] [Related]
13. BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells.
Burdak-Rothkamm S; Rothkamm K; McClelland K; Al Rashid ST; Prise KM
Cancer Lett; 2015 Jan; 356(2 Pt B):454-61. PubMed ID: 25304378
[TBL] [Abstract][Full Text] [Related]
14. Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven.
Wang Y; Wiltshire T; Senft J; Wenger SL; Reed E; Wang W
Mol Cancer Ther; 2006 Dec; 5(12):3153-61. PubMed ID: 17172419
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer.
Cron KR; Zhu K; Kushwaha DS; Hsieh G; Merzon D; Rameseder J; Chen CC; D'Andrea AD; Kozono D
PLoS One; 2013; 8(9):e73710. PubMed ID: 24040035
[TBL] [Abstract][Full Text] [Related]
16. Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway.
Jang SW; Jung JK; Kim JM
Cell Cycle; 2016 Sep; 15(17):2336-45. PubMed ID: 27398742
[TBL] [Abstract][Full Text] [Related]
17. FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.
Vilcheck SK; Ceryak S; O'Brien TJ; Patierno SR
Mutat Res; 2006 Nov; 610(1-2):21-30. PubMed ID: 16893675
[TBL] [Abstract][Full Text] [Related]
18. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.
Wang X; Kennedy RD; Ray K; Stuckert P; Ellenberger T; D'Andrea AD
Mol Cell Biol; 2007 Apr; 27(8):3098-108. PubMed ID: 17296736
[TBL] [Abstract][Full Text] [Related]
19. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
[TBL] [Abstract][Full Text] [Related]
20. Suppression of BRCA1 sensitizes cells to proteasome inhibitors.
Gu Y; Bouwman P; Greco D; Saarela J; Yadav B; Jonkers J; Kuznetsov SG
Cell Death Dis; 2014 Dec; 5(12):e1580. PubMed ID: 25522274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
